BOM/543322 (BOM/543322)

Bombay Stock Exchange: BOM/543322 · INR

₹1,401

+57.05 (+4.2%)· Recorded snapshot

Market cap	171.8B
Revenue (ttm)	25.9B
Net income (ttm)	6B
EPS (ttm)	₹49.0
P/E (trailing)	28.6x
P/E (forward)	22.4x
Dividend	₹5.00 (0.36%)
Volume	16,204

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 25.9B
Net income (ttm): 6B
EPS (ttm): ₹49.0
P/E (trailing): 28.6x
P/E (forward): 22.4x
Market cap: 171.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E22.4

P25 n/aP50 n/aP75 n/a

Trailing P/E28.6

P25 n/aP50 n/aP75 n/a

ROE18.4

P25 n/aP50 n/aP75 n/a

ROIC21.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/543322 indicators

Market & fundamental data

Available fields

227

Groups with data

Currency

INR

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-10-29
Employees	2,272
Employees change	69
Employees growth	3.13%
Enterprise value	INR 164.5B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	2001
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	INE03Q201024
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Market cap	INR 171.8B
Next earnings date	2026-10-29
Price	INR 1,400.50
Price currency	INR
Sector	Healthcare
SIC code	2833
Stock price date	2026-10-28
Symbol	bom/543322
Website	https://www.alivus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	27.67x
Average P/E ratio (3Y)	22.62x
Average P/E ratio (5Y)	19.2x
Earnings yield	3.5%
EV/Earnings	27.29x
EV/EBIT	21.71x
EV/EBITDA	19.63x
EV/FCF	63.69x
EV/Sales	6.35x
FCF / EV yield	1.57%
FCF yield	1.5%
Forward P/E	22.39x
Graham number	525.7774
Graham upside	-60.86%
Industry forward P/E	33.04x
Industry P/E	38.96x
Lynch fair value	INR 479.90
Lynch upside	-64.28%
P/B ratio	5.16x
P/E ratio	28.56x
P/FCF ratio	66.5x
P/OCF ratio	30.39x
P/S ratio	6.63x
Price / tangible book value	5.2x
Price/EBITDA ratio	20.5x
Sector forward P/E	36.13x
Sector P/E	45.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	29.25%
EBITDA margin	32.36%
Effective tax rate	24.67%
FCF margin	10.12%
Gross margin	59.42%
Operating margin	29.25%
Pretax margin	30.9%
Profit margin	23.28%
Profit per employee	INR 2.7M
Profitable quarters	9
Profitable years	2
Revenue per employee	INR 11.4M
ROA	12.21%
ROA (5Y)	13.88%
ROCE	20.79%
ROE	18.36%
ROE (5Y)	22.08%
ROIC	21.9%
ROIC (5Y)	24.11%
Tax / revenue	7.63%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	21.61%
EPS growth (Q)	31.68%
EPS growth (QoQ)	-1.58%
EPS growth 3Y	6.76%
EPS growth 5Y	7.31%
EPS growth quarters	5
EPS growth years	1
FCF growth	14.65%
FCF growth 3Y	21.74%
FCF growth 5Y	-4.2%
Gross profit growth	15.15%
Gross profit growth (Q)	16.26%
Gross profit growth 3Y	8.16%
Gross profit growth 5Y	9.12%
Net income growth	21.66%
Net income growth (Q)	31.71%
Net income growth (QoQ)	-1.59%
Net income growth 3Y	6.9%
Net income growth 5Y	10.18%
Net income growth quarters	5
Net income growth years	1
OCF growth	44.41%
OCF growth 3Y	22.71%
OCF growth 5Y	7.82%
Operating income growth	19.88%
Operating income growth (Q)	23.11%
Operating income growth 3Y	5.58%
Operating income growth 5Y	5.36%
Revenue growth	7.93%
Revenue growth (Q)	6.41%
Revenue growth (QoQ)	-7.07%
Revenue growth 3Y	4.81%
Revenue growth 5Y	5.17%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -3.1B
Depreciation and amortization	INR 804.5M
EBIT	INR 7.6B
EBITDA	INR 8.4B
EPS	INR 49.03
Financing cash flow	INR -643.4M
Free cash flow	INR 2.6B
Gross profit	INR 15.4B
Income taxes	INR 2B
Investing cash flow	INR -5.7B
Net borrowing	INR -80.2M
Net cash flow	INR -690.8M
Net income	INR 6B
Operating income	INR 7.6B
Revenue	INR 25.9B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 271.02
Debt / EBITDA	0.07
Debt / equity	0.02
Debt / FCF	0.22
Interest coverage	139.61
Net cash (debt)	INR 7.3B
Net cash / market cap	4.22%
Net cash growth	47.43%
Net debt / EBITDA	-0.87
Net debt / equity	-0.22
Net debt / FCF	-2.81
Piotroski F-Score	5
Shareholders' equity	INR 33.3B
Tangible book value	INR 33B
Tangible book value per share	INR 268.58
Total cash	INR 7.8B
Total debt	INR 567.7M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.69
Current ratio	5.22
Inventory turnover	1.67
Quick ratio	3.72
Working capital	INR 21.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.04%
Dividend growth	0%
Dividend growth (3Y)	-51.38%
Dividend growth years	0
Dividend payment date	2026-10-08
Dividend payment years	2
Dividend payout frequency	Annual
Dividend per share	INR 5.00
Dividend yield	0.36%
Ex-dividend date	2026-09-01
Last dividend	INR 5.00
Payout ratio	10.2%
Shareholder yield	0.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	INR 1,186.27
1D price change	4.25%
1M price change	2.59%
1M total return	2.59%
1W price change	10.02%
1W total return	10.02%
1Y price change	52.31%
1Y return CAGR	52.9%
1Y total return	52.86%
20-day SMA	INR 1,331.86
200-day SMA	INR 1,117.86
3M price change	23.88%
3M total return	24.33%
3Y price change	124.37%
3Y return CAGR	31.29%
3Y total return	126.37%
50-day SMA	INR 1,361.27
50-day SMA vs 200-day SMA	50over200
52-week high	INR 1,495.30
52-week high date	2026-08-31
52-week low	INR 830.00
52-week low date	2026-01-22
5Y price change	119.64%
5Y return CAGR	20.28%
5Y total return	151.76%
6M price change	33.96%
6M total return	34.44%
All-time high	INR 1,495.30
All-time high date	2026-08-31
All-time low	INR 369.00
All-time low date	2023-02-22
Average true range (ATR)	INR 49.71
Average volume	5.4K
Change from 52-week high	-6.34%
Change from 52-week low	68.74%
Change from all-time high	-6.34%
Change from all-time low	279.54%
Change from open	4.27%
Day's gap	-0.02%
Dollar volume	INR 22.7M
High price	INR 1,407.05
Low price	INR 1,332.65
Monthly RSI	71.74
Open price	INR 1,343.15
Position in 52-week range	91.2%
Previous close	INR 1,343.45
Price vs 150-day SMA	18.06%
Price vs 20-day SMA	5.15%
Price vs 200-day SMA	25.28%
Price vs 50-day SMA	2.88%
Relative volume	3.35
RSI	60.95
Sharpe ratio	1.46
Sharpe ratio (3Y)	0.85
Sharpe ratio (5Y)	0.57
Sortino ratio	2.82
Sortino ratio (3Y)	1.5
Sortino ratio (5Y)	1.08
Volume	16.2K
Weekly RSI	64.44
YTD price change	52.69%
YTD total return	53.23%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30.9M
Shares change (QoQ)	-0%
Shares change (YoY)	0.04%
Shares held by insiders	0%
Shares held by institutions	10.52%

Deeper analysis on BOM/543322

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/543322 report

Is a complete BOM/543322 research report available?

No complete published report is available for bom/543322 (BOM/543322) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/543322 (BOM/543322)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/543322

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/543322 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/543322

Frequently asked questions